These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9544580)

  • 21. Monocyte chemoattractant protein-1 and interleukin-8 levels in urine and serum of patents with hemolytic uremic syndrome.
    van Setten PA; van Hinsbergh VW; van den Heuvel LP; Preyers F; Dijkman HB; Assmann KJ; van der Velden TJ; Monnens LA
    Pediatr Res; 1998 Jun; 43(6):759-67. PubMed ID: 9621985
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The prognostic significance of urinary interleukin 6 in IgA nephropathy.
    Dohi K; Iwano M; Muraguchi A; Horii Y; Hirayama T; Ogawa S; Shiiki H; Hirano T; Kishimoto T; Ishikawa H
    Clin Nephrol; 1991 Jan; 35(1):1-5. PubMed ID: 2007290
    [TBL] [Abstract][Full Text] [Related]  

  • 23. C5a enhances Vδ1 T cells recruitment via the CCL2-CCR2 axis in IgA nephropathy.
    Deng S; Zhou F; Wang F; Jiang Y; Tang J; Hu X; Luo L; Jin Y; Huang L; Sun D; Xiao G; Feng J; Li X
    Int Immunopharmacol; 2023 Dec; 125(Pt A):111065. PubMed ID: 37862725
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Latent IgA deposition from donor kidney is the major risk factor for recurrent IgA nephropathy in renal transplantation.
    Moriyama T; Nitta K; Suzuki K; Honda K; Horita S; Uchida K; Yumura W; Tanabe K; Toma H; Nihei H; Yamaguchi Y
    Clin Transplant; 2005; 19 Suppl 14():41-8. PubMed ID: 15955168
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased excretion of tumor necrosis factor alpha and interleukin 1 beta in urine from patients with IgA nephropathy and Schönlein-Henoch purpura.
    Wu TH; Wu SC; Huang TP; Yu CL; Tsai CY
    Nephron; 1996; 74(1):79-88. PubMed ID: 8883024
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effects of astragalus on renal tubulointerestitial lesions and expression of NF-kappaB and MCP-1 in renal tissues in rat experimental IgA nephropathy].
    Zhang GZ; Wu XC; Peng XJ; Yi ZW; Mo SH; Tan H
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Apr; 10(2):173-8. PubMed ID: 18433541
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tissue-specific expression of renin-angiotensin system components in IgA nephropathy.
    Miyake-Ogawa C; Miyazaki M; Abe K; Harada T; Ozono Y; Sakai H; Koji T; Kohno S
    Am J Nephrol; 2005; 25(1):1-12. PubMed ID: 15644622
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical significance of serum and mesangial galactose-deficient IgA1 in patients with IgA nephropathy.
    Wada Y; Matsumoto K; Suzuki T; Saito T; Kanazawa N; Tachibana S; Iseri K; Sugiyama M; Iyoda M; Shibata T
    PLoS One; 2018; 13(11):e0206865. PubMed ID: 30388165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proliferation and Cytokine Production of Human Mesangial Cells Stimulated by Secretory IgA Isolated from Patients with IgA Nephropathy.
    Liang Y; Zhang J; Zhou Y; Xing G; Zhao G; Liu Z
    Cell Physiol Biochem; 2015; 36(5):1793-1808. PubMed ID: 26184511
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Histological differences in new-onset IgA nephropathy between children and adults.
    Ikezumi Y; Suzuki T; Imai N; Ueno M; Narita I; Kawachi H; Shimizu F; Nikolic-Paterson DJ; Uchiyama M
    Nephrol Dial Transplant; 2006 Dec; 21(12):3466-74. PubMed ID: 16935895
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monocyte chemoattractant protein-1 levels in patients with glomerular disease.
    Rovin BH; Doe N; Tan LC
    Am J Kidney Dis; 1996 May; 27(5):640-6. PubMed ID: 8629622
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urinary levels of monocyte chemoattractant protein (MCP)-1 and disease activity in patients with IgA nephropathy.
    Saitoh A; Suzuki Y; Takeda M; Kubota K; Itoh K; Tomino Y
    J Clin Lab Anal; 1998; 12(1):1-5. PubMed ID: 9484662
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced expression of C chemokine lymphotactin in IgA nephropathy.
    Ou ZL; Hotta O; Natori Y; Sugai H; Taguma Y; Natori Y
    Nephron; 2002 Jun; 91(2):262-9. PubMed ID: 12053063
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A quantitative study of mesangial deposits and glomerular monocytes/macrophages in IgA-nephropathy and proliferative mesangial (non-IgA) glomerulonephritis.
    Danilewicz M; Wagrowska-Danilewicz M
    J Nephrol; 1998; 11(5):255-60. PubMed ID: 9831239
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinicopathological correlation of intrarenal cytokines and chemokines in IgA nephropathy.
    Lim CS; Yoon HJ; Kim YS; Ahn C; Han JS; Kim S; Lee JS; Lee HS; Chae DW
    Nephrology (Carlton); 2003 Feb; 8(1):21-7. PubMed ID: 15012746
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urinary fractalkine and monocyte chemoattractant protein-1 as possible predictors of disease activity of childhood glomerulonephritis.
    Aizawa T; Imaizumi T; Tsuruga K; Watanabe S; Yoshida H; Kumagai N; Ito E; Tanaka H
    Tohoku J Exp Med; 2013 Dec; 231(4):265-70. PubMed ID: 24284376
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intervention of crescentic glomerulonephritis by antibodies to monocyte chemotactic and activating factor (MCAF/MCP-1).
    Wada T; Yokoyama H; Furuichi K; Kobayashi KI; Harada K; Naruto M; Su SB; Akiyama M; Mukaida N; Matsushima K
    FASEB J; 1996 Oct; 10(12):1418-25. PubMed ID: 8903512
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The ratio of epidermal growth factor to monocyte chemotactic peptide-1 in the urine predicts renal prognosis in IgA nephropathy.
    Torres DD; Rossini M; Manno C; Mattace-Raso F; D'Altri C; Ranieri E; Pontrelli P; Grandaliano G; Gesualdo L; Schena FP
    Kidney Int; 2008 Feb; 73(3):327-33. PubMed ID: 17943082
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urinary levels of interleukin-8 (IL-8) and disease activity in patients with IgA nephropathy.
    Huang F; Horikoshi S; Kurusu A; Shibata T; Suzuki S; Funabiki K; Shirato I; Tomino Y
    J Clin Lab Anal; 2001; 15(1):30-4. PubMed ID: 11170231
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protective effects of tubular liver-type fatty acid-binding protein against glomerular damage in murine IgA nephropathy.
    Zuo N; Suzuki Y; Sugaya T; Osaki K; Kanaguchi Y; Wang L; Tomino Y
    Nephrol Dial Transplant; 2011 Jul; 26(7):2127-37. PubMed ID: 21109611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.